Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734979 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02734979: Completed NA study, sponsored by Stanford University.
NCT02734979 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734979, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To investigate whether addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Interventions
- DEVICE Biobridge and lymph node transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-07-20 |
| Est. Completion | 2020-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734979
The ClinicalTrials.gov registry entry for NCT02734979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biobridge and lymph node transfer is the first listed.
NCT02734979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02734979 about?
NCT02734979 is a clinical study titled "Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema". To investigate whether addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
What is the current status of trial NCT02734979?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-07-20. Estimated completion is 2020-10-29.
What interventions are being tested in trial NCT02734979?
The interventions under investigation include: Biobridge and lymph node transfer (DEVICE).
Who is sponsoring clinical trial NCT02734979?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.